Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious gastroenteritis: are they all the same?

D Baert1, M De Man, L Oosterbosch

  • 1Department of Gastroenterology OLV Hospital, Aalst, Belgium.

Acta Clinica Belgica
|January 1, 1995
PubMed
Summary

Campylobacter jejuni and Salmonella infections are common causes of gastroenteritis in hospitalized patients. While both can cause pancreatitis, C. jejuni is linked to visceritis, and Salmonella to kidney issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preconditions Contributing to Interprofessional Collaboration in the Management of COPD in Primary Care: A Scoping Review.

International journal of integrated care·2025
Same author

Developing an interprofessional collaboration for COPD patients in primary care: a participatory action research approach.

NPJ primary care respiratory medicine·2025
Same author

Quality outcome measures project in IBD: a proof-of-concept benchmarking study in three Belgian IBD units.

Acta gastro-enterologica Belgica·2024
Same author

Evaluation of the safety and effectiveness after switch from adalimumab originator to biosimilar SB5 in patients with inflammatory bowel disease in a real-life setting.

Acta gastro-enterologica Belgica·2022
Same author

Lessons learned about appendiceal neuroendocrine neoplasms from data analysis of the Belgian Cancer Registry 2010-2015.

Acta gastro-enterologica Belgica·2021
Same author

An atypical cause of right lower abdominal pain: amoebiasis, a family cluster.

Acta gastro-enterologica Belgica·2021

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • Campylobacter jejuni and Salmonella spp. are leading causes of infectious gastroenteritis in hospitalized patients.
  • These pathogens frequently affect individuals in gastroenterology and geriatrics departments.
  • Understanding their distinct clinical presentations and complications is crucial for patient management.

Purpose of the Study:

  • To compare the epidemiological and clinical characteristics of Campylobacter jejuni and Salmonella spp. infections in hospitalized patients.
  • To highlight the differential complications associated with each pathogen.
  • To describe the typical patient demographics and disease spectrum for each infection.

Main Methods:

  • Retrospective analysis of hospitalized patients diagnosed with Campylobacter jejuni or Salmonella spp. gastroenteritis.

Related Experiment Videos

  • Comparison of patient demographics, clinical symptoms, biochemical findings, and complication rates.
  • Review of medical records for disease outcomes and complications.
  • Main Results:

    • Campylobacter jejuni gastroenteritis predominantly affects a younger patient population compared to Salmonella spp.
    • Both pathogens can induce biochemical pancreatitis, typically without clinical significance.
    • Serious complications differ: visceritis is more common with C. jejuni, while renal function impairment is more associated with Salmonella spp.
    • Salmonella spp. infections are associated with an asymptomatic carrier state, whereas C. jejuni may lead to recurrent disease.

    Conclusions:

    • Campylobacter jejuni and Salmonella spp. exhibit distinct epidemiological and clinical profiles in hospitalized patients.
    • Recognizing pathogen-specific complications, such as visceritis for C. jejuni and renal impairment for Salmonella, is vital for targeted treatment.
    • The differing disease trajectories, including carrier states and recurrence, necessitate tailored patient monitoring and management strategies.